Ugochukwu Ebubechukwu, MD 🫀

Out now in @AmericanHeartJ ! 🔥 Excited to share our latest work on "Visual Arts & Representation in Cardiology" co-led with @simplyonyi under the mentorship of @CMichaelGibson! We explored the past, present and future role of visual arts in cardiovascular medicine! 🫀

Earthset. The Artemis II crew captured this view of an Earthset on April 6, 2026, as they flew around the Moon. The image is reminiscent of the iconic Earthrise image taken by astronaut Bill Anders 58 years earlier as the Apollo 8 crew flew around the Moon.

@DrMarthaGulati Yes, it's truly remarkable and amazing!!! 🌑🚀

This morning as I ran, I stared at the moon 🌕 wondering where Artemis II was. What a miracle unfolding in our time. With all the unsettling things going on, it is really nice to have something this remarkable and uniting happening 🚀

We're going farther than ever before 🚀 Today, the Artemis II crew will break the record for how far humans have traveled from Earth as they fly around the far side of the Moon. Coverage begins at 1 p.m. EDT (1700 UTC). Watch Artemis II make history: nasa.gov/ways-to-watch/

It was such an exceptional experience attending and presenting at the American College of Cardiology 2026 in New Orleans 🫀 #ACC #CardioTwitter

@Marioo_Rizk Congratulations, Mario! 👏🏾

That's us! 🌍 The Artemis II crew captured beautiful, high-resolution images of our home planet during their journey to the Moon. As @Astro_Christina put it: "You guys look great."

Excellent discussion by my 🌟mentee @simplyonyi on the impact of cardiometabolic disease in a young woman. @jaideeppatelmd @PSatishMD @GarimaVSharmaMD @EugeniaGianos @DrEugeneYang

@simplyonyi @AKulkarniMD A very interesting and educational piece too! Congratulations to you and your team, Onyi! 🫀👏🏾👏🏾

This case highlights the intersection of early ASCVD and reproductive health, an area with meaningful clinical implications. Thankful to all my coauthors and to @AKulkarniMD for her guidance and supervision. #cardiovascularprevention

Excited to share that our case report titled - ‘Premature Atherosclerotic Cardiovascular Disease in a Young Woman of Childbearing Age: Cardiovascular and Obstetric Implications’, has been accepted at @AJPCardio and is now available online! 🎉🫀 sciencedirect.com/science/articl…

Artemis II astronaut Christina Koch is set to become the 1st woman to fly around the moon 🌕

We're going around the Moon. Come watch with us. Artemis II's four-astronaut crew is lifting off from @NASAKennedy on an approximately 10-day mission that will bring us closer to living on the Moon and Mars. The launch window opens at 6:24pm ET (2224 UTC). twitter.com/i/broadcasts/1…

@KTamirisaMD @JACCJournals @CandiceSilvers1 @DineshKalra @GarimaVSharmaMD @JamalRanaMD @PRodriguezMD @RBP0612 @DrJMieres @docbhardwaj @HeartOTXHeartMD Congratulations, @KTamirisaMD ! 👏🏾

#ACC26 Thank you for recognizing my work & the Top Reviewer recognition for #JACCAdvances ! @JACCJournals @CandiceSilvers1 @DineshKalra @GarimaVSharmaMD Appreciate your sponsorship! 🏷️ friends @JamalRanaMD @PRodriguezMD @RBP0612 @DrJMieres @docbhardwaj @HeartOTXHeartMD

THRIVE Trial Food-is-medicine intervention targeting BP in Black & Hispanic adults with HTN 🌱 Exploring whether improved access to healthy nutrition can meaningfully lower BP Key Results if this pilot study 🌱6.8 mmHg⤵️ in intervention arm at 24 weeks (between group diff was 6.5 mmHg The cost is not that much more than many medications & we should invest in access to healthy food #ACC26 #CardioTwitter #HealthEquity #THRIVE #bloodpressure #DASHdiet #cardiotwitter

New #ACC26 trial insights: Outcomes in Patients With Atrial Fibrillation Randomised to Receive Left Atrial Appendage Closure or Oral Anticoagulation — primary results of the CHAMPION‑AF Clinical Trial, with key highlights reported onsite by @CMichaelGibson 👇 #ESCTVOnTheRoad

@NEJM To me, anything invasive needs to prove ample superiority over standard care to be recommended.

Presented at #ACC26: Among patients with atherosclerotic cardiovascular disease, targeting an LDL cholesterol level below 55 mg per deciliter led to a lower 3-year risk of cardiovascular events than targeting a level below 70 mg per deciliter. Full Ez-PAVE trial results: nejm.org/doi/full/10.10… Editorial: Paving the Road toward Targeted Lipid Lowering nejm.org/doi/full/10.10… @ACCinTouch

💥CHAMPION-AF compares LAA occlusion vs DOAC therapy. Is device-based therapy ready to compete with anticoagulation? ➡️ Key results: Primary efficacy endpoint-composite of CV death, stroke, or systemic embolism: 5.7% LAAO 🆚 4.8% DOAC over 3 years: LAAO NonInferior to DOAC 💃🏻31% Women 🎷no diff in strokes ⤴️ bleeding with DOAC vs LAAC Take home: sometimes the right choice for the right patient with SDM so they understand the risks vs benefits #ACC26 #AFib #StrokePrevention 📎 @NEJM nejm.org/doi/full/10.10…

The #CVPrev Trials tomorrow at #ACC26 that I can’t wait to hear: #LBCT Session II (Afternoon: 3:45–4:45 PM CT) 💥KARDINAL •Tonlamarsen (RNA-based therapy) for Uncontrolled hypertension 💥VESALIUS-CV •Evolocumab in patients without established ASCVD 💥Ez-PAVE •safety and benefits of taking LDL cholesterol<55 mg/dL 💥GoFreshRx •DASH-based grocery intervention

Success in cardiology isn’t performing procedures. It’s preventing events.

It still feels surreal! Alhamdulillaah. It has been a rewarding journey of hardwork and sacrifice. I am excited to share that I have matched into IM Residency at @EmoryMedicine. Grateful for the support from family, friends, and mentors in the US, UK and Nigeria. #Match2026